35
views
0
recommends
+1 Recommend
2 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Development of a Clinical Decision Support System for Severity Risk Prediction and Triage of COVID-19 Patients at Hospital Admission: an International Multicenter Study

      research-article

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background

          The outbreak of the coronavirus disease 2019 (COVID-19) has globally strained medical resources and caused significant mortality.

          Objective

          To develop and validate machine-learning model based on clinical features for severity risk assessment and triage for COVID-19 patients at hospital admission.

          Method

          725 patients were used to train and validate the model including a retrospective cohort of 299 hospitalised COVID-19 patients at Wuhan, China, from December 23, 2019, to February 13, 2020, and five cohorts with 426 patients from eight centers in China, Italy, and Belgium, from February 20, 2020, to March 21, 2020. The main outcome was the onset of severe or critical illness during hospitalisation. Model performances were quantified using the area under the receiver operating characteristic curve (AUC) and metrics derived from the confusion-matrix.

          Results

          The median age was 50.0 years and 137 (45.8%) were men in the retrospective cohort. The median age was 62.0 years and 236 (55.4%) were men in five cohorts. The model was prospectively validated on five cohorts yielding AUCs ranging from 0.84 to 0.89, with accuracies ranging from 74.4% to 87.5%, sensitivities ranging from 75.0% to 96.9%, and specificities ranging from 57.5% to 88.0%, all of which performed better than the pneumonia severity index. The cut-off values of the low, medium, and high-risk probabilities were 0.21 and 0.80. The online-calculators can be found at www.covid19risk.ai.

          Conclusion

          The machine-learning model, nomogram, and online-calculator might be useful to access the onset of severe and critical illness among COVID-19 patients and triage at hospital admission.

          Abstract

          An internationally validated model, nomogram, and online- calculator for severity risk assessment and triage of COVID-19 patients at hospital admission.

          Related collections

          Most cited references19

          • Record: found
          • Abstract: found
          • Article: not found

          Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China

          Summary Background A recent cluster of pneumonia cases in Wuhan, China, was caused by a novel betacoronavirus, the 2019 novel coronavirus (2019-nCoV). We report the epidemiological, clinical, laboratory, and radiological characteristics and treatment and clinical outcomes of these patients. Methods All patients with suspected 2019-nCoV were admitted to a designated hospital in Wuhan. We prospectively collected and analysed data on patients with laboratory-confirmed 2019-nCoV infection by real-time RT-PCR and next-generation sequencing. Data were obtained with standardised data collection forms shared by WHO and the International Severe Acute Respiratory and Emerging Infection Consortium from electronic medical records. Researchers also directly communicated with patients or their families to ascertain epidemiological and symptom data. Outcomes were also compared between patients who had been admitted to the intensive care unit (ICU) and those who had not. Findings By Jan 2, 2020, 41 admitted hospital patients had been identified as having laboratory-confirmed 2019-nCoV infection. Most of the infected patients were men (30 [73%] of 41); less than half had underlying diseases (13 [32%]), including diabetes (eight [20%]), hypertension (six [15%]), and cardiovascular disease (six [15%]). Median age was 49·0 years (IQR 41·0–58·0). 27 (66%) of 41 patients had been exposed to Huanan seafood market. One family cluster was found. Common symptoms at onset of illness were fever (40 [98%] of 41 patients), cough (31 [76%]), and myalgia or fatigue (18 [44%]); less common symptoms were sputum production (11 [28%] of 39), headache (three [8%] of 38), haemoptysis (two [5%] of 39), and diarrhoea (one [3%] of 38). Dyspnoea developed in 22 (55%) of 40 patients (median time from illness onset to dyspnoea 8·0 days [IQR 5·0–13·0]). 26 (63%) of 41 patients had lymphopenia. All 41 patients had pneumonia with abnormal findings on chest CT. Complications included acute respiratory distress syndrome (12 [29%]), RNAaemia (six [15%]), acute cardiac injury (five [12%]) and secondary infection (four [10%]). 13 (32%) patients were admitted to an ICU and six (15%) died. Compared with non-ICU patients, ICU patients had higher plasma levels of IL2, IL7, IL10, GSCF, IP10, MCP1, MIP1A, and TNFα. Interpretation The 2019-nCoV infection caused clusters of severe respiratory illness similar to severe acute respiratory syndrome coronavirus and was associated with ICU admission and high mortality. Major gaps in our knowledge of the origin, epidemiology, duration of human transmission, and clinical spectrum of disease need fulfilment by future studies. Funding Ministry of Science and Technology, Chinese Academy of Medical Sciences, National Natural Science Foundation of China, and Beijing Municipal Science and Technology Commission.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Clinical Characteristics of Coronavirus Disease 2019 in China

            Abstract Background Since December 2019, when coronavirus disease 2019 (Covid-19) emerged in Wuhan city and rapidly spread throughout China, data have been needed on the clinical characteristics of the affected patients. Methods We extracted data regarding 1099 patients with laboratory-confirmed Covid-19 from 552 hospitals in 30 provinces, autonomous regions, and municipalities in mainland China through January 29, 2020. The primary composite end point was admission to an intensive care unit (ICU), the use of mechanical ventilation, or death. Results The median age of the patients was 47 years; 41.9% of the patients were female. The primary composite end point occurred in 67 patients (6.1%), including 5.0% who were admitted to the ICU, 2.3% who underwent invasive mechanical ventilation, and 1.4% who died. Only 1.9% of the patients had a history of direct contact with wildlife. Among nonresidents of Wuhan, 72.3% had contact with residents of Wuhan, including 31.3% who had visited the city. The most common symptoms were fever (43.8% on admission and 88.7% during hospitalization) and cough (67.8%). Diarrhea was uncommon (3.8%). The median incubation period was 4 days (interquartile range, 2 to 7). On admission, ground-glass opacity was the most common radiologic finding on chest computed tomography (CT) (56.4%). No radiographic or CT abnormality was found in 157 of 877 patients (17.9%) with nonsevere disease and in 5 of 173 patients (2.9%) with severe disease. Lymphocytopenia was present in 83.2% of the patients on admission. Conclusions During the first 2 months of the current outbreak, Covid-19 spread rapidly throughout China and caused varying degrees of illness. Patients often presented without fever, and many did not have abnormal radiologic findings. (Funded by the National Health Commission of China and others.)
              Bookmark
              • Record: found
              • Abstract: found
              • Article: found

              Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus–Infected Pneumonia in Wuhan, China

              In December 2019, novel coronavirus (2019-nCoV)-infected pneumonia (NCIP) occurred in Wuhan, China. The number of cases has increased rapidly but information on the clinical characteristics of affected patients is limited.
                Bookmark

                Author and article information

                Journal
                Eur Respir J
                Eur. Respir. J
                ERJ
                erj
                The European Respiratory Journal
                European Respiratory Society
                0903-1936
                1399-3003
                02 July 2020
                : 2001104
                Affiliations
                [1 ]The D-Lab, Department of Precision Medicine, GROW - School for Oncology, Maastricht University Medical Center+, Maastricht, The Netherlands
                [2 ]Department of Radiology, The Central Hospital of Wuhan, Huazhong University of Science and Technology, Wuhan, China
                [3 ]Department of Radiology and Nuclear Medicine, GROW- School for Oncology and Developmental Biology, Maastricht University Medical Center+, Maastricht, The Netherlands
                [4 ]Department of Ultrasound, The Central Hospital of Huangshi, Huangshi, China
                [5 ]Department of Respiratory Medicine, CHU of Liège, Liège, Belgium
                [6 ]Department of Infectiology, CHU of Liège, Liège, Belgium
                [7 ]Department of Radiology, China Resources Wuhan Iron and Steel Hospital, Wuhan, China
                [8 ]Department of Radiology, The Central Hospital of Shaoyang, Shaoyang, China
                [9 ]Department of Medical Imaging Center, Nanfang Hospital, Southern Medical University, Guangzhou, China
                [10 ]Department of Intensive Care Unit, The Central Hospital of Wuhan, Huazhong University of Science and Technology, Wuhan, China
                [11 ]National Institute for Infectious Diseases – IRCCS, , Rome, Italy
                [12 ]Department of Biomedical, Clinical and Experimental Sciences “Mario Serio”, University of Florence, Florence, Italy
                [13 ]Unit of Respiratory Pathophysiology, Respiratory Diseases and Allergy Clinic, Department of Internal Medicine and Medical Specialties, University of Genoa, IRCCS Ospedale Policlinico San Martino, Genoa, Italy
                [14 ]Unit of Interventional Pulmonology, IRCCS Ospedale Policlinico San Martino, Genoa, Italy
                [15 ]Nuclear Medicine and Oncological Imaging, Department of Medical Physics, CHU of Liège, Liège, Belgium
                [16 ]Department of Radiology, Affiliated Zhongshan Hospital of Dalian University, Dalian, China
                [17 ]Guangyao Wu and Pei Yang are joint first authors
                Author notes
                Guangyao Wu, The D-Lab, Department of Precision Medicine, GROW - School for Oncology, Maastricht University Medical Center+, 6229 ER, Maastricht, The Netherlands. E-mail: g.wu@ 123456maastrichtuniversity.nl ; Xiang Wang, Department of Radiology, The Central Hospital of Wuhan, Huazhong University of Science and Technology, Wuhan, 430014, China. E-mail: drwangxiang385@ 123456163.com
                Author information
                https://orcid.org/0000-0001-7911-5123
                https://orcid.org/0000-0001-7800-1730
                https://orcid.org/0000-0002-2349-5646
                https://orcid.org/0000-0001-7961-0191
                Article
                ERJ-01104-2020
                10.1183/13993003.01104-2020
                7331655
                32616597
                bea69930-d50f-4fea-aa59-0a88ac87d3ad
                Copyright ©ERS 2020

                This article is open access and distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0.

                History
                : 9 April 2020
                : 11 June 2020
                Funding
                Funded by: H2020 European Research Council , open-funder-registry 10.13039/100010663;
                Award ID: ImmunoSABR - n° 733008, PREDICT - ITN - n° 76627
                Funded by: Euradiomics
                Award ID: EMR4
                Funded by: China Scholarship Council , open-funder-registry 10.13039/501100004543;
                Award ID: 201808210318
                Funded by: ERC advanced grant
                Award ID: 694812 - Hypoximmuno
                Categories
                Original Article

                Respiratory medicine
                Respiratory medicine

                Comments

                Comment on this article